Advertisement

Topics

SCHWARZ PHARMA, Inc Company Profile

23:40 EDT 1st May 2016 | BioPortfolio

SCHWARZ PHARMA, Inc. is the U.S. headquarters of SCHWARZ PHARMA AG, a mid-sized, multi-national pharmaceutical company focusing on the development and marketing of innovative therapeutics. SCHWARZ PHARMA leverages its strengths to secure new product flow through collaborative alliances with academia, research organizations and biotech companies. This development strategy is supported and funded by the established position of SCHWARZ PHARMA as a global pharmaceutical company with a marketing presence in all key international markets.

Location

6140 W Executive Dr
Mequon
Wisconsin
53092
United States of America

Contact

Email: mdi@schwarzusa.com


News Articles [1069 Associated News Articles listed on BioPortfolio]

Forenap Pharma E.U.R.L. - Strategic SWOT Analysis Review

Recently added to the BioPortfolio report store, Forenap Pharma E.U.R.L. - Strategic SWOT Analysis Review is a new report from GlobalData published on 2015-09-11. This 15-page report is available in ...

German stocks - Factors to watch on December 28

FRANKFURT, Dec 28 (Reuters) - The DAX top-30 index looked set to open unchanged on Monday, according to premarket data from brokerage Lang & Schwarz at 0711 GMT.

German stocks - Factors to watch on November 9

FRANKFURT, Nov 9 (Reuters) - The DAX top-30 index looked set to open 0.1 percent higher on Monday, according to premarket data from brokerage Lang & Schwarz at 0707 GMT.

German stocks - Factors to watch on November 10

FRANKFURT, Nov 10 (Reuters) - The DAX top-30 index looked set to open 0.2 percent higher on Tuesday, according to premarket data from brokerage Lang & Schwarz at 0747 GMT.

German stocks - Factors to watch on November 4

FRANKFURT, Nov 4 (Reuters) - The DAX top-30 index looked set to open 0.3 percent higher on Wednesday, according to premarket data from brokerage Lang & Schwarz at 0727 GMT.

German stocks - Factors to watch on January 28

FRANKFURT, Jan 28 (Reuters) - The DAX top-30 index looked set to open 0.8 percent lower on Thursday, according to premarket data from brokerage Lang & Schwarz at 0715 GMT.

German stocks - Factors to watch on November 20

FRANKFURT, Nov 20 (Reuters) - The DAX top-30 index looked set to open 0.2 percent lower on Friday, according to premarket data from brokerage Lang & Schwarz at 0709 GMT.

German stocks - Factors to watch on February 29

FRANKFURT, Feb 29 (Reuters) - The DAX top-30 index looked set to open 1.0 percent lower on Monday, according to premarket data from brokerage Lang & Schwarz at 0729 GMT.

Drugs and Medications [248 Associated Drugs and Medications listed on BioPortfolio]

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 0.5 mg

Fluoride [Libertas Pharma, Inc.]

Fluoride Chewable Tablets 1 mg

Metoprolol tartrate [Med-Health Pharma, LLC]

Metoprolol Tartrate Tablets, USP

Urea [Libertas Pharma, Inc.]

Rx Only 45% Urea Nail Gel In a vehicle containing Camphor, Eucalyptus Oil and Menthol )

Eloxatin [Aventis Pharma Ltd.]

PubMed Articles [36 Associated PubMed Articles listed on BioPortfolio]

Digital health revolution: Perfect storm or perfect opportunity for pharmaceutical R&D?

The convergence of technology and medicine has pushed healthcare to the brink of a major disruption that pharma has, until recently, been slow to recognize. Tech players have pioneered the emerging fi...

Semi-Markov Arnason-Schwarz models.

We consider multi-state capture-recapture-recovery data where observed individuals are recorded in a set of possible discrete states. Traditionally, the Arnason-Schwarz model has been fitted to such d...

Pharma Success in Product Development-Does Biotechnology Change the Paradigm in Product Development and Attrition.

The biotechnology segment of the overall biopharma industry has existed for only about 40-45 years, as a driver of new product development. This driving force was initiated with the FDA approval of r...

Response to: 'Paracetamol: is all the concern valid?' by Schwarz and Mullins.

Management of osteoarthritis (OA) with the pharma-standard supplement FlexiQule (Boswellia): a 12-week registry.

This registry study assessed the pharma-standard supplement FlexiQule (Boswellia extract in capsules) in the management of symptoms associated to osteoarthritis (OA) also managed with the 'standard ma...

Clinical Trials [62 Associated Clinical Trials listed on BioPortfolio]

A Relative Bioavailability Study of Moexipril HCl 15 mg Tablets Under Fasting Conditions

The purpose of this study is to compare the relative bioavailability of Moexipril HCl 15mg tablets (by Paddock Laboratories, Inc.) with that of Univasc® 15mg tablets (by Schwarz Pharma) f...

To Demonstrate the Relative Bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam Tablets In Healthy Adults Volunteers Under Fasting Conditions

To demonstrate the relative bioavailability of Sandoz Inc. and UCB Pharma, Inc (Keppra) 750 mg Levetiracetam tablets in healthy adult volunteers under fasting conditions.

A Bioequivalence Study of Cefadroxil From Duricef 1 gm F.C.T (GSK) and Biodroxil 1 gm F.C.T (Novartis Pharma)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Cefadroxil from Duricef 1 gm Film Coated tablets(Smthkline Beecham Egypt,LLC aff...

Pharma-Pen (Formerly Innoject) Auto-Injectory TIV

The purpose of this study is to evaluate the safety, effectiveness, and tolerability, of the Pharma-Pen(TM) intramuscular (IM) and subcutaneous (SC) auto-injector systems used by untrained...

A Bioequivalence Study of Dexlansoprazole From Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant 60 mg Delayed Release (DR) Capsules (Takeda Pharmaceuticals America Inc., USA)

Comparative randomized, single dose, two-way crossover open-label study to determine the bioequivalence of Dexlansoprazole from Doxirazole 60 mg Capsules (Hikma Pharma,Egypt)and Dexilant...

Companies [693 Associated Companies listed on BioPortfolio]

SCHWARZ PHARMA, Inc

SCHWARZ PHARMA, Inc. is the U.S. headquarters of SCHWARZ PHARMA AG, a mid-sized, multi-national pharmaceutical company focusing on the development and marketing of innovative therapeutics. SCHWARZ PHA...

Schwarz Pharma Spain

Nuestros esfuerzos se concentran en las áreas terapéuticas del sistema nervioso central, el sistema cardiovascular y urología. SCHWARZ PHARMA desarrolla y comercializa medicamentos innovadores para...

SCHWARZ PHARMA Deutschland GmbH

SCHWARZ PHARMA AG is a publicly traded company, which develops and markets innovative drugs with the focus on Central Nervous System (CNS) as well as cardiovascular and gastro-intestinal diseases empl...

SCHWARZ PHARMA AG

SCHWARZ PHARMA AG is a publicly traded company, which develops and markets innovative drugs with the focus on Central Nervous System (CNS) as well as cardiovascular and gastro-intestinal diseases empl...

H3 Pharma Incorporated

H3 Pharma Inc. is a Venture Pharma focusing on the development of human therapeutic products oriented towards age-related disorders. At H3 Pharma, we aim to be the best at identifying, evaluating and ...

More Information about "SCHWARZ PHARMA, Inc" on BioPortfolio

We have published hundreds of SCHWARZ PHARMA, Inc news stories on BioPortfolio along with dozens of SCHWARZ PHARMA, Inc Clinical Trials and PubMed Articles about SCHWARZ PHARMA, Inc for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of SCHWARZ PHARMA, Inc Companies in our database. You can also find out about relevant SCHWARZ PHARMA, Inc Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...


Corporate Database Quicklinks



Searches Linking to this Company Record